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Background
Quantitative MR molecular imaging allows for the detec-
tion of targeted contrast agents to diagnose disease states
and monitor response to therapy, such as anti-angiogenic
therapy in atherosclerosis and cancer with aνb3-integrin
targeted perfluorocarbon (PFC) nanoparticles. Recently,
19F MR using a 19F/1H dual-tuned RF coil has been uti-
lized to directly image and quantify the fluorinated core of
these PFC nanoparticle (NP) emulsions. However, low
concentrations of these fluorine agents in the body, in
conjunction with varying RF coil sensitivity profiles (B1-
field inhomogeneities) raise obstacles to accurate quantifi-
cation. This study presents a strategy to more accurately
quantify the sparse 19F signal from PFC NP emulsions
with a 1H image-based Actual Flip-angle Imaging (AFI)
B1-mapping correction to the
19F and 1H images.
Methods
New Zealand White Rabbits (2 kg) were implanted with a
VX2 adenocarcinoma tumor (2-3 cm) in the hind leg.
Angiogenesis imaging was performed 2 weeks post
implantation, under ketamine/xylazine anesthesia. An
aνb3-integrin targeted perfluoro-octyl bromide (PFOB)
nanoparticle emulsion was prepared, and injected intra-
venously 3 hours before imaging. MR data were acquired
on a 3T clinical whole-body scanner (Achieva, Philips
Healthcare) with a dual 19F/1H spectrometer system and
a dual-tuned transmit/receive single loop surface RF coil
(7×12 cm). A simultaneous 19F/1H gradient echo (GRE)
imaging sequence was used with: 19F offset frequency
on the center of the PFOB CF2 peak, 15 4-mm slices,
140 mm FOV, 483 matrix, a = 60°, TE/TR = 2.2/8.5 ms,
21 min scan time. The B1 field was mapped using an AFI
sequence with matching geometry. Using the flip angle
map and a model of the GRE signal, a spatially-depen-
dent calibration mask was calculated in MATLAB (Math-
Works) and used to compensate the 1H and 19F signal
intensities for the GRE sequence.
Results
PFC NP targeted the tumor neovasculature, and provided
localized 19F signal as expected. Figure 1 displays the
uncorrected (top) and corrected (bottom) 1H images with
the 19F signal superimposed, using the AFI (middle) B1-
mapping correction technique. After correction, the 1H
signal intensity profile as a function of distance from the
surface coil (located at right) is improved. After the same
correction to the 19F signal, the measured concentration
of nanoparticles when compared to a standard was 10.2 ±
1.0 mM19F, versus 9.0 ± 2.2 mM19F before correction.
Conclusions
An image-based B1-mapping correction acquired with
1H
can be used to correct signal intensities for 19F and 1H
images of angiogenesis in an in vivo rabbit model. The
correction results in a more homogeneous 1H image of
the anatomy and facilitates accurate measurement of
bound aνb3-integrin targeted nanoparticles with
19F
imaging.
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Figure 1 Top: uncorrected 1H image of rabbit model with
angiogenesis-targeted 19F imaging (blue overlay). Middle: AFI B1
map (% actual/requested flip angle). Bottom: 1H and 19F
superimposed images using AFI B1-mapping correction.
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